Reuters

(Reuters) - Aethon Energy will acquire Tellurian's upstream assets for $260 million and purchase two million tons per annum (mtpa) of liquefied natural gas (LNG) from its Driftwood LNG plant, the companies said on Wednesday.

Shares of Tellurian were up 6.1% in premarket trading.

Reuters reported earlier this month that U.S. LNG developer Tellurian had sent home more than a dozen workers from its upstream gas production business amid sale... (continue reading...)

By Emma Rumney

LONDON (Reuters) - Nicotine alternatives used in vapes being launched in the U.S. and abroad, such as 6-methyl nicotine, may be more potent and addictive than nicotine itself, though the scientific data remains incomplete, according to the U.S. Food and Drug Administration (FDA) and independent researchers.

The synthetic substances - which have a chemical structure similar to that of nicotine - are not subject to U.S.... (continue reading...)

(Reuters) - Shares of American Airlines slumped on Wednesday after the carrier cut its profit forecast for the current quarter, citing weakening pricing power despite expectations for record travel demand in the summer season.

American Airlines shares were down nearly 8% in premarket trading on Wednesday, dragging peers Delta Air, Southwest Airlines and United Airlines, which all fell between 1.5% and 2.5%.

The Fort Worth, Texas-based... (continue reading...)

By Anne Kauranen

HELSINKI (Reuters) - Helsinki-based video game developer Supercell is seeking to attract new groups of players with its first product launch in more than five years, Chief Executive Ilkka Paananen said, as mobile games face increasing competition from other entertainment for people's free time.

Majority-owned by China's Tencent, Supercell has previously put out five games, including Clash of Clans, one of the world's most... (continue reading...)

(Reuters) - Merck said on Wednesday it would acquire eye disease drug developer EyeBio for up to $3 billion, in the latest acquisition by the U.S. drugmaker as it looks to boost growth.

Under the deal, Merck would pay $1.3 billion upfront and up to $1.7 billion in future milestone payments.

Merck had said in February it was in the market for deals of up to around $15 billion, and has already struck two major deals this year, as its... (continue reading...)